文献速递糖尿病

舒张压与ACR是2型糖尿病无心血管疾病患者动脉僵硬度可改变的危险因素

Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在174例病程<10年、无心血管疾病且eGFR≥60 mL/min/1.73 m2的2型糖尿病患者中评估CKD-MBD生物标志物与CAVI的关系,并以34名年龄匹配健康人作本地参考;结果仅54%患者CAVI正常,年龄、舒张压、ACR和血清Klotho是CAVI的独立正向预测因素。

要点

  • 2型糖尿病无心血管疾病患者中仅54% CAVI正常(<8),动脉僵硬度常已异常。
  • CAVI与年龄、血红蛋白1A1c、收缩压、舒张压正相关,与25-羟基维生素D负相关。
  • 多因素分析中年龄、舒张压、ACR和血清Klotho是CAVI的独立正向预测因素。

核心结论

  • 在无明确心血管疾病和慢性肾功能不全的2型糖尿病患者中,CAVI常为病理值;舒张压和ACR是动脉僵硬度可改变的危险因素,因此值得最佳评估。

研究设计与样本

  • 研究纳入174例2型糖尿病患者(中位年龄56岁,男/女100/74),糖尿病病程<10年,eGFR≥60 mL/min/1.73 m2且无大血管并发症。
  • 34名年龄匹配健康人(男/女13/21,年龄53.5(50.0-57.7)岁,eGFR 107.5(97.0-119.7)mL/min/1.73 m2)作为CAVI(病理值≥8)和新型CKD-MBD生物标志物的本地参考对照。

主要发现

  • 尿白蛋白与肌酐比值(ACR)平均为8.5 mg/g(5.6-17.2),12.6%的患者显示病理值,提示早期糖尿病肾病。
  • 血清甲状旁腺激素、成纤维细胞生长因子23和硬骨素高于对照组,而1,25-二羟基维生素D和Klotho低于对照组。
  • CAVI正常(<8)者仅占54%,CAVI与年龄(P < 0.001)、血红蛋白1A1c(P = 0.036)、收缩压(P = 0.021)和舒张压(P = 0.001)呈正相关,与25-羟基维生素D(P = 0.046)呈负相关。
  • 多因素分析中,年龄、舒张压、ACR和血清Klotho是CAVI的独立正向预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate early, before the onset of cardiovascular events and of chronic renal insufficiency, the association between chronic kidney disease (CKD)-mineral bone disorder (MBD) biomarkers and vascular stiffness [Cardio Ankle Vascular Index (CAVI)] in the course of type 2 diabetes (T2DM). METHOD: We evaluated 174 T2DM patients [median age 56 years; male/female (M/F) 100/74] with diabetes duration < 10 years and without decreased estimated glomerular filtration rate (eGFR; ≥60 mL/min/1.73 m2) or macrovascular complications. Thirty-four age-matched healthy subjects [M/F 13/21; age 53.5 (50.0-57.7) years; eGFR 107.5 (97.0-119.7) mL/ min1.73 m2] served as local reference control for CAVI (pathological: ≥8) and the novel CKD-MBD biomarkers. RESULTS: Albumin-to-creatinine ratio (ACR) averaged 8.5 mg/g (5.6-17.2) with 12.6% of the patients showing pathologic values, indicative of incipient diabetic nephropathy. Serum parathyroid hormone, fibroblast growth factor 23, and sclerostin were higher while 1,25-dihydroxyvitamin D and Klotho were lower than a control group. CAVI was normal (<8) in only 54% and correlated positively with age (P < 0.001), hemoglobin 1A1c (P = 0.036), and systolic (P = 0.021) and diastolic blood pressure (DBP) (P = 0.001) and negatively correlated with 25-hydroxyvitamin D (P = 0.046). In multivariate analysis, age, DBP, ACR, and serum Klotho were independent positive predictors of CAVI. CONCLUSION: In the absence of overt cardiovascular disease and of chronic renal insufficiency, CAVI is frequently pathologic in T2DM. DBP and ACR are modifiable risk factors of vascular stiffness in T2DM, thus warranting optimal assessment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Leto G, Tartaglione L, Rotondi S, et al. Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease. J Clin Endocrinol Metab. 2022. PMID: 35595474. doi:10.1210/clinem/dgac291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。